Journals / Anatomy / 2018 / Cilt: 12 - Sayı: 1

Foetal hepatorenal toxicity and intrauterine growth retardation in pregnant Wistar rats treated with artemether

Journal
Anatomy
Pages
1–6
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The foetalkidney of artemether-treated groups also showed disorganised renal structure, atrophic and degenerated glomeruli with acutetubular necrosis.Conclusion: Artemether administration to pregnant albino rats causes intrauterine growth retardation or stunted growth,as well as foetal hepatorenal toxicity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Foetal hepatorenal toxicity and foetal morphology were evaluated following artemether administration to pregnantWistar albino rats.Methods: Twenty pregnant Wistar rats weighing between 180–200 g were divided into four groups (n=5, each) with Group 1serving as the control.
📊
Key Findings & Data:Groups 2, 3 and 4 received 1.1 mg, 2.2 mg and 3.3 mg per kilogram body weight artemether, respectivelyorally, twice daily for three days on day 7, 8 and 9 of pregnancy.
💡
Conclusion & Impact:The foetalkidney of artemether-treated groups also showed disorganised renal structure, atrophic and degenerated glomeruli with acutetubular necrosis.Conclusion: Artemether administration to pregnant albino rats causes intrauterine growth retardation or stunted growth,as well as foetal hepatorenal toxicity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Foetal hepatorenal toxicity and foetal morphology were evaluated following artemether administration to pregnantWistar albino rats.Methods: Twenty pregnant Wistar rats weighing between 180–200 g were divided into four groups (n=5, each) with Group 1serving as the control. Groups 2, 3 and 4 received 1.1 mg, 2.2 mg and 3.3 mg per kilogram body weight artemether, respectivelyorally, twice daily for three days on day 7, 8 and 9 of pregnancy. The animals were sacrificed on day 20 of pregnancy and foetuseswere harvested and evaluated for morphological changes. Foetal body weight and crown-rump length (CRL) were measured;alpha-fetoprotein (AFP) was assayed using amniotic fluid, and foetal kidney and liver were evaluated histologically for toxicity.Results: There was a significant decrease in body weight, CRL and AFP of the treated groups compared to the control. The foetalliver of the treated groups revealed distorted cytoarchitecture, marked hepatocyte inflammation and hepatic necrosis. The foetalkidney of artemether-treated groups also showed disorganised renal structure, atrophic and degenerated glomeruli with acutetubular necrosis.Conclusion: Artemether administration to pregnant albino rats causes intrauterine growth retardation or stunted growth,as well as foetal hepatorenal toxicity.

🔖

Cite This Article

UMOH, I. U., JİMMY, E. O. (2022). Foetal hepatorenal toxicity and intrauterine growth retardation in pregnant Wistar rats treated with artemether. Anatomy, Cilt: 12 - Sayı: 1, 1–6. https://ajindex.com/articles/439488

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. World Health Organisation. WHO global malaria programme: World Malaria Report 2014. Geneva: WHO Press; 2014. World Health Organisation. The WHO prequalification project. The global portfolio of new antimalarial medicines under development. Clin Pharmacol Ther 2009;85:584–95.
  2. Burke E, Deasy J. Hasson R, McCormack R, Randhawa V, Walsh P. Antimalarial drugs from nature. Trinity Student Medical Journal 2003;4:19. Mayxay M, Thongpraseuth V, Khanthavong M, Lindegardh N, Barends M, Keola S, Pongvongsa T, Phompida S, Phetsouvanh R, Stepniewska K, White NJ, Newton PN. An open, randomised comparison of artesunate plus mefloquine vs dihydroartemisininpiperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People’s Democratic Republic (Laos). Trop Med Int Health 2006;11:1157–65.
  3. Faye B, Ndiaye JL, Tine R, Sylla K, Gueye AH, Colle LA, Gaye OA. Randomised trial of artesunate/mefloquine vs artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children. Am J Trop Med Hyg 2010;82:140–4.
  4. Frey SG, Chelo D, Kinkela MN, Djouknone F, Tietche F, Hatz C, Weber P. Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety. Malar J 2010;9: 291–9.
  5. Akpanyung EO, Bassey UE, Usoh I, Iba IU. Effect of combined administration of artequin and pefloxacin on some indices of liver and renal functions of male Wistar albino rats. PharmacologyOnLine 2015;3:84–90.
  6. Etim OE, Bassey UE, Charles GE, Sambo EE, Akpan EJ. Toxicological evaluation of some artemisinin combination therapies (acts) on the kidney and liver of Wistar albino rats. International Journal of Biochemistry Research and Review 2016;9:1–5.
  7. Bhabagrahi R, Jyotirmoyee J, Satyajit S, Bandana R. Reproductive profile of artemisinins in albino rats. Indian J Pharmacol 2010;42: 192–3. El-Dakdoky MH. Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy. Food Chem Toxicol 2009;47:1437–41.
  8. Li Q, Weina PJ. Severe embryotoxicity of artemisinin derivatives in experimental animals, but possibly safe in pregnant women. Molecules 2009;15:40–57.
  9. Clarke RL, Lerman SA, Cox EM, Gristwood WE, White TE. Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count. Birth Defects Res (Part